These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29126844)

  • 1. Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-confined Prostate Cancer.
    Barqawi AB; Huebner E; Krughoff K; O'Donnell CI
    Urology; 2018 Feb; 112():126-131. PubMed ID: 29126844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
    Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
    Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal cryosurgical ablation of the prostate: a single institute's perspective.
    Hale Z; Miyake M; Palacios DA; Rosser CJ
    BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer.
    Saliken JC; Donnelly BJ; Brasher P; Ali-Ridha N; Ernst S; Robinson J
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):199-208. PubMed ID: 10082109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Performing a 3D Mapping Biopsy Prior to Primary Cryotherapy for the Treatment of Prostate Cancer.
    Barqawi A; Pessoa RR; Al-Musawi M; MacDermott T; O'Donnell CI
    Urology; 2020 Oct; 144():171-176. PubMed ID: 32711012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
    Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
    J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.
    Tourinho-Barbosa RR; Sanchez-Salas R; Claros OR; Collura-Merlier S; Bakavicius A; Carneiro A; Stabile A; Moschini M; Cathala N; Tobias-Machado M; Cathelineau X
    J Urol; 2020 Feb; 203(2):320-330. PubMed ID: 31437121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
    Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
    BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.
    Ward JF; Jones JS
    BJU Int; 2012 Jun; 109(11):1648-54. PubMed ID: 22035200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up.
    Onik G
    Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient reported outcomes among treatment modalities for prostate cancer.
    Johnson ME; Zaorsky NG; Martin JM; Ruth K; Greenberg RE; Uzzo RG; Hayes SB; Smaldone MC; Kutikov A; Viterbo R; Chen DY; Hallman MA; Sobczak ML; Horwitz EM
    Can J Urol; 2016 Dec; 23(6):8535-8545. PubMed ID: 27995848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
    Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
    J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cryosurgery of the prostate for nonsurgical candidates.
    Al Ekish S; Nayeemuddin M; Maddox M; Pareek G
    JSLS; 2013; 17(3):423-8. PubMed ID: 24018080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
    Shah TT; Peters M; Eldred-Evans D; Miah S; Yap T; Faure-Walker NA; Hosking-Jervis F; Thomas B; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Minhas S; Winkler M; Arya M; Ahmed HU
    Eur Urol; 2019 Jul; 76(1):98-105. PubMed ID: 30638633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole and hemi-gland cryoablation for primary localized prostate cancer: Short and medium-term oncological and functional outcomes.
    Bossier R; Sanguedolce F; Territo A; Vanacore D; Martínez C; Regis F; Gallioli A; Mercade A; Mosquera L; Aumatell J; Balana J; Carlderon J; Huguet J; Gaya JM; Palou J; Breda A
    Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):172-178. PubMed ID: 32033834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
    Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
    Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: feasibility study.
    Kim FJ; Cerqueira MA; Almeida JC; Pompeo A; Sehrt D; Calheiros JM; Martins FA; Molina WR
    Int Braz J Urol; 2012; 38(5):620-6. PubMed ID: 23131504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted focal therapy for the management of organ confined prostate cancer.
    Barqawi AB; Stoimenova D; Krughoff K; Eid K; O'Donnell C; Phillips JM; Crawford ED
    J Urol; 2014 Sep; 192(3):749-53. PubMed ID: 24641910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.